← feed

Is NCT03499106 results overdue?

Yes — results are overdue. Primary completion was 2018-07-06; the FDAAA-801 reporting deadline (2019-07-06) passed 2588 days ago and no results are posted on ClinicalTrials.gov.

A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of Praliciguat (IW-1973) in Healthy Volunteers

NCT IDNCT03499106 ↗
SponsorCyclerion Therapeutics (INDUSTRY)
Public issuerCyclerion Therapeutics, Inc. — CYCN (CIK 0001755237) best-effort name match, 95% conf — verify on EDGAR ↗
PhasePHASE1
StatusCOMPLETED
Primary completion2018-07-06 (ACTUAL)
Reporting deadline2019-07-06 (completion + 365d)
Days overdue2588
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-07-03 · SHA-256 b29aef9a81e2908b… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03499106. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →